PNPLA3 and metabolic dysfunction-associated steatohepatitis: Our study demonstrates that the PNPLA3 I148M variant disrupts metabolic perturbations and confirms the critical impact of fasting and feeding cycles on PNPLA3 expression,15 emphasizing its functional and pathogenic role during MASLD/MASH progression.